{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:02:14Z","timestamp":1780380134544,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100003011","name":"Immune Deficiency Foundation","doi-asserted-by":"publisher","award":["U24AI86837"],"award-info":[{"award-number":["U24AI86837"]}],"id":[{"id":"10.13039\/100003011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaci.2025.09.019","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:13:36Z","timestamp":1759162416000},"page":"1693-1705.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bruton tyrosine kinase modulates systemic immune activation to bacterial translocation in primary antibody deficiencies"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7160-2960","authenticated-orcid":false,"given":"Hsi-en","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Radigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Roudko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Hsuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsay","family":"Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghee","family":"Kim-Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.09.019_bib1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine"},{"key":"10.1016\/j.jaci.2025.09.019_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","article-title":"Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry","volume":"38","author":"Feuille","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib6","article-title":"Interferon signature in the blood in inflammatory common variable immune deficiency","volume":"8","author":"Park","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.09.019_bib7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","article-title":"Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency","volume":"137","author":"Cols","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","article-title":"Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2014possible immunologic and clinical consequences","volume":"87","author":"Aukrust","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2249.1993.tb03386.x","article-title":"Increased IL-6 gene expression and production in patients with common variable immunodeficiency","volume":"92","author":"Pandolfi","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0091-6749(05)80207-6","article-title":"Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency","volume":"86","author":"Adelman","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2249.2012.04655.x","article-title":"Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia","volume":"170","author":"Litzman","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144777","article-title":"Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency","volume":"6","author":"Ho","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2025.09.019_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib15","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrmicro2848","article-title":"Microbial translocation in HIV infection: causes, consequences and treatment opportunities","volume":"10","author":"Sandler","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jaci.2025.09.019_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.703310","article-title":"Bacterial translocation as inflammatory driver in Crohn\u2019s disease","volume":"9","author":"Linares","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib19","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","article-title":"Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection","volume":"141","author":"Sandler","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2025.09.019_bib20","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20140039","article-title":"Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders","volume":"211","author":"Perreau","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2018.06.012","article-title":"Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses","volume":"143","author":"Romberg","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2025.09.019_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.09.019_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41375-020-01072-6","article-title":"Inhibitors targeting Bruton\u2019s tyrosine kinase in cancers: drug development advances","volume":"35","author":"Wen","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2025.09.019_bib25","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3389\/fimmu.2017.01454","article-title":"Bruton\u2019s tyrosine kinase: an emerging key player in innate immunity","volume":"8","author":"Weber","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201656","article-title":"BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity","volume":"218","author":"Bittner","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10875-019-00640-5","article-title":"Factors beyond lack of antibody govern pulmonary complications in primary antibody deficiency","volume":"39","author":"Weinberger","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","article-title":"The health status and quality of life of adults with X-linked agammaglobulinemia","volume":"118","author":"Howard","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.09.019_bib30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s10875-023-01502-x","article-title":"A registry study of 240 patients with X-linked agammaglobulinemia living in the USA","volume":"43","author":"Hernandez-Trujillo","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 Update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib34","first-page":"7.1.1","article-title":"Isolation of whole mononuclear cells from peripheral blood and cord blood","volume":"Chapter 7","author":"Fuss","year":"2009","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib35","article-title":"Genetics and clinical phenotypes in common variable immunodeficiency","volume":"14","author":"Cunningham-Rundles","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.jaci.2025.09.019_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","article-title":"Contamination in low microbial biomass microbiome studies: issues and recommendations","volume":"27","author":"Eisenhofer","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jaci.2025.09.019_bib37","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1128\/JCM.01018-11","article-title":"Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation","volume":"49","author":"Kramski","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaci.2025.09.019_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","article-title":"Unique action of interleukin-18 on T cells and other immune cells","volume":"9","author":"Nakanishi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.2100057","article-title":"IFN-\u03b3 induces IL-15 trans-presentation by epithelial cells via IRF1","volume":"208","author":"Kim","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/376260a0","article-title":"A novel receptor involved in T-cell activation","volume":"376","author":"Cocks","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.09.019_bib42","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2002-02-0445","article-title":"The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production","volume":"100","author":"Howie","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.185.7.1163","article-title":"Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors","volume":"185","author":"Patel","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fcell.2019.00212","article-title":"CCL19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention","volume":"7","author":"Yan","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2010-0265OC","article-title":"The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis","volume":"45","author":"Yang","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib46","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2017.01390","article-title":"CCL3 enhances antitumor immune priming in the lymph node via IFN\u03b3 with dependency on natural killer cells","volume":"8","author":"Allen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.joca.2020.01.009","article-title":"CCL3\/CCR1 mediates CD14+CD16\u2212 circulating monocyte recruitment in knee osteoarthritis progression","volume":"28","author":"Zhao","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jaci.2025.09.019_bib48","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.biocel.2003.10.019","article-title":"Macrophage inflammatory protein-1","volume":"36","author":"Maurer","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib49","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1038\/s41375-021-01287-1","article-title":"CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes\/macrophages enhancing their tumoricidal activity","volume":"35","author":"Stoll","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2025.09.019_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.1500369","article-title":"Specific contributions of CSF-1 and GM-CSF to the dynamics of the mononuclear phagocyte system","volume":"195","author":"Louis","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib51","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib52","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3389\/fimmu.2018.02900","article-title":"CD5, an undercover regulator of TCR signaling","volume":"9","author":"Voisinne","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib53","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1182\/blood-2007-05-092429","article-title":"Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients","volume":"111","author":"Cassani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8+ T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.09.019_bib55","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1073\/pnas.0702815104","article-title":"CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock","volume":"104","author":"Sarrias","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.09.019_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib57","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib58","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202151","article-title":"Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation","volume":"218","author":"Huen","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib59","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","article-title":"CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis","volume":"63","author":"Aff\u00f2","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2025.09.019_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857050","article-title":"Seeking relevant biomarkers in common variable immunodeficiency","volume":"13","author":"Ho","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2021.06.008","article-title":"Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications","volume":"149","author":"Abyazi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clim.2007.10.005","article-title":"Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia","volume":"126","author":"Taneichi","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib63","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1073\/pnas.1119238109","article-title":"Bruton\u2019s tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.09.019_bib64","article-title":"Bruton\u2019s tyrosine kinase and protein kinase C \u03bc are required for TLR7\/9-induced IKK\u03b1 and IRF-1 activation and interferon-\u03b2 production in conventional dendritic cells","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.09.019_bib65","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaci.2013.12.1085","article-title":"Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation","volume":"133","author":"Lougaris","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib66","doi-asserted-by":"crossref","first-page":"26258","DOI":"10.1074\/jbc.M301484200","article-title":"Bruton\u2019s tyrosine kinase is a Toll\/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4","volume":"278","author":"Jefferies","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.09.019_bib67","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10875-012-9706-z","article-title":"Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia","volume":"32","author":"Gonz\u00e1lez-Serrano","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib68","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaci.2006.01.037","article-title":"Bruton\u2019s tyrosine kinase is not essential for LPS-induced activation of human monocytes","volume":"117","author":"P\u00e9rez de Diego","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2010.06.011","article-title":"TLR signaling and effector functions are intact in XLA neutrophils","volume":"137","author":"Marron","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib70","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.176.6.3635","article-title":"Bruton\u2019s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production","volume":"176","author":"Horwood","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib71","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1038\/s41598-017-06342-5","article-title":"Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency","volume":"7","author":"Mirsafian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2025.09.019_bib72","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/314819","article-title":"In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus\u2013infected subjects","volume":"180","author":"da Silva","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2025.09.019_bib74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/655229","article-title":"Persistent microbial translocation and immune activation in HIV-1\u2013infected South Africans receiving combination antiretroviral therapy","volume":"202","author":"Cassol","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2025.09.019_bib75","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/gutjnl-2012-303557","article-title":"Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn\u2019s disease","volume":"63","author":"Guti\u00e9rrez","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2025.09.019_bib76","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2007.03481.x","article-title":"Anti\u2013tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID)","volume":"150","author":"Chua","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib77","article-title":"Amelioration of IFN-\u03b3 and TNF-\u03b1\u2013induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.09.019_bib78","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/s41598-018-38322-8","article-title":"Modulation of intestinal epithelial permeability by plasma from patients with Crohn\u2019s disease in a three-dimensional cell culture model","volume":"9","author":"Xu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2025.09.019_bib79","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.09.019_bib80","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-15-1965","article-title":"Disruption of in vivo chronic lymphocytic leukemia tumor\u2013microenvironment interactions by ibrutinib\u2014findings from an investigator-initiated phase II study","volume":"22","author":"Niemann","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2025.09.019_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2025.09.019_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630942","article-title":"Comparative Analysis of BTK inhibitors and mechanisms underlying adverse effects","volume":"9","author":"Estupinan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","article-title":"X-linked agammaglobulinemia. A clinical and molecular analysis","volume":"75","author":"Ochs","year":"1996","journal-title":"Medicine"},{"key":"10.1016\/j.jaci.2025.09.019_bib85","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJMoa2110297","article-title":"Rilzabrutinib, an oral BTK inhibitor, in immune thrombocytopenia","volume":"386","author":"Kuter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib86","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4049\/jimmunol.2001130","article-title":"Preclinical efficacy and anti-inflammatory mechanisms of action of the Bruton tyrosine kinase inhibitor rilzabrutinib for immune-mediated disease","volume":"206","author":"Langrish","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib87","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10875-014-0056-x","article-title":"Autoimmunity and inflammation in X-linked agammaglobulinemia","volume":"34","author":"Hernandez-Trujillo","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.09.019_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.668131","article-title":"Targeting bruton\u2019s tyrosine kinase in inflammatory and autoimmune pathologies","volume":"9","author":"Neys","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaci.2025.09.019_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg1915","article-title":"In vivo Bruton\u2019s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis","volume":"16","author":"Nagesh","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2025.09.019_bib90","doi-asserted-by":"crossref","first-page":"L435","DOI":"10.1152\/ajplung.00234.2013","article-title":"Silencing Bruton\u2019s tyrosine kinase in alveolar neutrophils protects mice from LPS\/immune complex\u2013induced acute lung injury","volume":"307","author":"Krupa","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2025.09.019_bib91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3892\/mmr.2017.6553","article-title":"Inhibition of BTK protects lungs from trauma\u2014hemorrhagic shock\u2013induced injury in rats","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jaci.2025.09.019_bib92","article-title":"Inhibition of Bruton\u2019s tyrosine kinase protects against burn sepsis-induced intestinal injury","volume":"9","author":"Wan","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925009832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925009832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:34:42Z","timestamp":1780202082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925009832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0091674925009832"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.09.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bruton tyrosine kinase modulates systemic immune activation to bacterial translocation in primary antibody deficiencies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}